Zika mexico
Ended Awarded Last action
- Contract number
- 75N91018F00060
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,392,433
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $2,392,433.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,392,433 |
About this award
This is a $2,392,433.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for work related to the "ZIKA MEXICO" project and the place of performance is Fort Detrick, MD. This contract does not have a set-aside designation. Leidos Biomedical Research Inc. is an experienced provider of research, development, and production services to federal agencies, particularly the NIH, in areas such as cancer, HIV/AIDS, influenza, COVID-19, and gene therapy research. The parent company, Leidos Holdings, Inc., has also served as a subcontractor on federal contracts, providing various goods and services. The contract has a completion date of September 16, 2023.
Quick answers
Who was awarded contract 75N91018F00060?
75N91018F00060 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 17, 2018.
How much is contract 75N91018F00060 worth?
The government has obligated $2,392,433 on 75N91018F00060.
Which agency awarded contract 75N91018F00060?
National Cancer Institute (National Institutes of Health) awarded 75N91018F00060, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91018F00060 an order under another contract?
Yes. 75N91018F00060 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00060 competed?
The extent of competition for 75N91018F00060 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award